Catheter-Associated Deep Venous Thrombosis Prevention: Which Path to Choose?
- PMID: 33616355
- DOI: 10.1097/CCM.0000000000004833
Catheter-Associated Deep Venous Thrombosis Prevention: Which Path to Choose?
Conflict of interest statement
The author has disclosed that he does not have any potential conflicts of interest.
Comment on
-
Efficacy of Early Prophylaxis Against Catheter-Associated Thrombosis in Critically Ill Children: A Bayesian Phase 2b Randomized Clinical Trial.Crit Care Med. 2021 Mar 1;49(3):e235-e246. doi: 10.1097/CCM.0000000000004784. Crit Care Med. 2021. PMID: 33372745 Free PMC article. Clinical Trial.
References
-
- Kaplan D, Casper TC, Elliott CG, et al. VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest. 2015; 148:1224–1230
-
- Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020; 4:4693–4738
-
- Sandoval JA, Sheehan MP, Stonerock CE, et al. Incidence, risk factors, and treatment patterns for deep venous thrombosis in hospitalized children: An increasing population at risk. J Vasc Surg. 2008; 47:837–843
-
- Raffini L, Huang YS, Witmer C, et al. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics. 2009; 124:1001–1008
-
- Knöfler R, Siegert E, Lauterbach I, et al. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines. Eur J Pediatr. 1999; 158Suppl 3S147–S150
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
